DUPILUMAB

Biologics and Immunomodulators for Immunobullous Diseases
Immunobullous Diseases
by Nishad Sathe, MD on
At ODAC 2023, we had the opportunity to learn about the latest in treatments for blistering diseases from Dr. Karl Saardi, Associate Professor and Director of Inpatient Dermatology at George Washington University. We focused on the pemphigus and pemphigoid group of diseases, which we will review and summarize here. Pemphigus The pemphigus group of diseases is characterized by intraepidermal auto …

Continue reading "Biologics and Immunomodulators for Immunobullous Diseases"

Practical Tips for Managing the Itchy Patient
itch
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Shawn Kwatra, associate professor of dermatology at Johns Hopkins University School of Medicine. Watch and learn Dr. Kwatra’s tips for a workup in an itchy patient. Itch falls on the neuroimmune spectrum, so learn why it’s important to determine if a dermatological condition is to bl …

Continue reading "Practical Tips for Managing the Itchy Patient"

Racial Disparities in Itch
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Shawn Kwatra, associate professor of dermatology at Johns Hopkins University School of Medicine. Dr. Kwatra shares what dermatology clinicians need to know about racial disparities in itch. Find out how disease prevalence and presentation play a role in these disparities. Watch as Dr. Kw …

Continue reading "Racial Disparities in Itch"

Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid
by NEXT STEPS IN DERM TEAM on
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the scalp, subtypes of alopecia areata include alopecia totalis with loss of all scalp hair and alopecia universalis with complete loss of all body hair. Although primarily an idiopathic condition, several …

Continue reading "Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid"

JDD April 2023 Issue Highlights
by NEXT STEPS IN DERM TEAM on
The April issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, features, and case reports,  with topics ranging from hormonal therapy in hidradenitis suppurativa, private equity in dermatology, vitiligo and its associated comorbidities, novel topical products for facial dyschromia, and many more.  Check out this month’s issue highlights straight …

Continue reading "JDD April 2023 Issue Highlights"